Simultaneous evaluation of fatty acid metabolism and myocardial flow in an explanted heart

Journal of Nuclear Medicine

Volumn 37, Issue 12, 1996, Pages 1990-1994

  Jonas, Margot ^a   Brandau, Wolfgang ^a   Vollet, Bernhard ^a   Weyand, Michael ^a   Fahrenkamp, Anke ^a   Gildehaus, Franz Josef ^a   Sciuk, Joachim ^a   Scheld, Hans H ^a   Schober, Otmar ^a  

^a UNIVERSITY OF MÜNSTER   (Germany)

Author keywords

dual isotope study; heart transplantation; iodine 123 fatty acid; myocardial viability; pathology

Indexed keywords

IODINE 131; METHOXY ISOBUTYL ISONITRILE TECHNETIUM TC 99M; RADIOPHARMACEUTICAL AGENT; THALLIUM 201; TRACER;

ARTICLE; CALCULATION; CELL VIABILITY; CORONARY ARTERY BLOOD FLOW; DRUG DISTRIBUTION; FATTY ACID METABOLISM; HEART PERFUSION; HEART TRANSPLANTATION; HUMAN; IMAGE ANALYSIS; PREOPERATIVE PERIOD; PRIORITY JOURNAL; QUANTITATIVE DIAGNOSIS; SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY; SURGICAL TECHNIQUE; TRANSLUMINAL CORONARY ANGIOPLASTY;

CORONARY CIRCULATION; HALF-LIFE; HEART; HEART TRANSPLANTATION; HUMANS; MALE; MIDDLE AGED; MYOCARDIUM; PHENYLPROPIONATES; TECHNETIUM TC 99M SESTAMIBI; THALLIUM RADIOISOTOPES;

EID: 0030455888     PISSN: 01615505     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (24)

1. Knapp FF Jr, Franken P, Kropp J. Cardiac SPECT with iodine-123-labeled fatty acids: evaluation of myocardial viability with BMIPP. J Nucl Med 1995;36:1022-1030.
2. Reske SN. Viability as seen with radiolabeled fatty acids - a new approach to a challenging problem. Eur J Nucl Med 1994;21:279-282.
3. Hansen CL. Preliminary report of an ongoing phase I/II dose range, safety and efficacy study of iodine-123-phenyl-pentadecanoic acid for the identification of viable myocardium. J Nucl Med 1994;35(suppl):38S-42S.
4. Kropp J, Fehske W, Krois M, et al. Influence of revascularization on myocardial perfusion, metabolism and function. Ann Nucl Med 1993;7:69-78.
5. Knapp FF Jr, Kropp J. Iodine-123-labeled fatty acids for myocardial single-photon emission tomography: current status and future perspectives. Eur J Nucl Med 1995;22:361-381.
6. Liefhold J. Phenylenverbrückte radiojodmarkierte Phenylfettsäuren (PHIPA). PhD thesis. University of Heidelberg, 1987.
7. Eisenhut M, Liefhold J Radioiodinated p-phenylene bridged fatty acids as new myocardial imaging agents: syntheses and biodistribution in rats. Appl Radiol Isot 1988;39:639-649.
8. Brandau W, Gildehaus F-J, Puskás C, et al. Iodine-123-iodo-PHIPA 3-10: a metabolic marker for myocardial SPECT investigations [Abstract]. Eur J Nucl Med 1994;21:786.
9. Jonas M, Brandau W, Vollet B, et al. Iodine-123-PHIPA 3-10: a SPECT tracer for assessment myocardial viability [Abstract], Eur J Nucl Med 1994;21:736.
10. 201Tl [Abstract]. J Nucl Cardiol 1995;2(suppl):S98.
11. Coenen HH, Dutschka KP, Brandau W. N.c.a. Cu(I)-assisted iodine-exchange on N-alkylated ortho-, meta- and para bromobenzamides. J Lab Compd Radiopharm 1994;35:222-223.
12. Charron M, Follansbee W, Ziady GM, Kormos RL. Assessment of biventricular cardiac function in patients with a novacor left ventricular assist device. J Heart Lung Transplant 1994; 13:263-267.
13. Franken PR, De Geeter F, Dendale P, et al. Abnormal free fatty acid uptake in subacute myocardial infarction after coronary thrombolysis: correlation with wall motion and inotropic reserve. J Nucl Med 1994;35:1758-1765.
14. Tamaki N, Tadamura E. Kudoh T, et al. Prognostic value of iodine-123-labeled BMIPP fatty acid analog imaging in patients with myocardial infarction. Eur J Nucl Med 1996;23:272-279.
15. Tamaki N, Kawamoto M, Yonekura Y, et al. Regional metabolic abnormality in relation to perfusion and wall motion in patients with myocardial infarction: assessment with emission tomography using an iodinated branched fatty acid analog. J Nucl Med 1992;33:659-667.
16. Saito T, Yasuda T, Gold HK, et al. Differentiation of regional perfusion and fatty acid uptake in zones of myocardial injury. Nucl Med Commun 1991;12:663-675.
17. 99mTc-sestamibi and 123I-β-methyl-iodo-phenyl pentadecanoic acid. Eur J Nucl Med 1994;21:283-291.
18. 123I-BMIPP myocardial imaging for myocardial infarction and hypertrophic cardiomyopalhy. Ann Nucl Med 1993;7:35-40.
19. 123I-phenyl)-pentadecanoic acid uptake in persisting defects on thallium-201 tomography in myocardial infarction. J Nucl Med 1991;32: 1353-1357.
20. Kuikka JT, Mussalo H, Hietakorpi S, Vanninen E, Länsimies E. Evaluation of myocardial viability with technetium-99m hexakis-2-methoxyisobutyl isonitrile and iodine-123 phenyl-pentadecanoic acid and single photon emission tomography. Eur J Nucl Med 1992;19:882-889.
21. Murray GL, Schad NC, Magil HL, Vander Zwagg R. Myocardial viability assessment with dynamic low-dose iodine-123-iodophenylpentadecanoic acid metabolic imaging: comparison with myocardial biopsy and reinjection SPECT thallium after myocardial infarction. J Nucl Med 1994;53(suppl):43S-48S.
22. Delbeke D, Lorenz CH, Votaw JR, et al. Estimation of left ventricular mass and infarct size from nitrogen-13-ammonia PET images based on pathological examination of explanted human hearts. J Nucl Med 1993;34:826-833.
23. Murray G, Schad N, Ladd W, et al. Metabolic cardiac imaging in severe coronary disease: assessment of viability with iodine-123-iodophenylpentadecanoic acid and multicrystal gamma camera and correlation with biopsy. J Nucl Med 1992;33:1269-1277.
24. Vanoverschelde J-L, Wijns W, Depre C, et al. Mechanism of chronic regional postischemic dysfunction in humans: new insights from the study of noninfarcted collateral-dependent myocardium. Circulation 1993;87:1513-1523.